Co-delivery of therapeutic protein and catalase-mimic nanoparticle using a biocompatible nanocarrier for enhanced therapeutic effect

S Kim, M Kim, S Jung, K Kwon, J Park, S Kim… - Journal of Controlled …, 2019 - Elsevier
Therapeutic proteins are indispensable in the treatment of various human diseases. Despite
the many benefits of therapeutic proteins, they also exhibit diverse side effects. Therefore …

Nanocapsules of therapeutic proteins with enhanced stability and long blood circulation for hyperuricemia management

X Zhang, D Xu, X Jin, G Liu, S Liang, H Wang… - Journal of Controlled …, 2017 - Elsevier
Among a broad spectrum of medical treatments, protein therapeutics holds tremendous
opportunities for the treatment of metabolic disorders, cancer, autoimmune diseases and etc …

Polyphenol-Based Nanoparticles for Intracellular Protein Delivery via Competing Supramolecular Interactions

Y Han, J Zhou, Y Hu, Z Lin, Y Ma, JJ Richardson… - ACS …, 2020 - ACS Publications
Intracellular delivery of proteins is a promising strategy for regulating cellular behavior and
therefore has attracted interest for biomedical applications. Despite the emergence of …

Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo

W Chen, F Li, C Qu, Y Liu, Y Wang, D Wang, X Zhang - Acta Biomaterialia, 2018 - Elsevier
To bypass the biological barriers during the drug delivery process, it is desirable to develop
smart nanoparticles (NPs) with flexible physical and chemical properties. In this study, a …

Polypeptide nanoparticles with pH-sheddable PEGylation for improved drug delivery

Z Gao, Z Zhang, J Guo, J Hao, P Zhang, J Cui - Langmuir, 2020 - ACS Publications
The variation of tumor microenvironments provides a tool for the construction of stimulus-
responsive nanomedicines to enhance drug delivery efficacy. Herein, the assembly of drug …

Protein Release by Controlled Desorption from Transiently Cationic Nanoparticles

TH Cheung, C Xue, DA Kurtz… - ACS Applied Materials & …, 2023 - ACS Publications
Therapeutic release from hydrogels is traditionally controlled by encapsulation within
nanoparticles; however, this strategy is limited for the release of proteins due to poor …

Protein nanoparticles: promising platforms for drug delivery applications

A Jain, SK Singh, SK Arya, SC Kundu… - … Biomaterials Science & …, 2018 - ACS Publications
The development of drug delivery systems using nanoparticles as carriers for small and
large therapeutic molecules remains a rapidly growing area of research. The advantages of …

Enzyme-induced morphological transformation of drug carriers: Implications for cytotoxicity and the retention time of antitumor agents

Z Hong, X Sun, X Sun, J Cao, Z Yang, Z Pan… - Materials Science and …, 2021 - Elsevier
Nanocarriers have been widely employed to deliver chemotherapeutic drugs for cancer
treatment. However, the insufficient accumulation of nanoparticles in tumors is an important …

Protein nanoparticles for intracellular delivery of therapeutic enzymes

LH Estrada, S Chu, JA Champion - Journal of pharmaceutical sciences, 2014 - Elsevier
The use of enzymes as therapeutics is very promising because of their catalytic activity and
specificity. However, intracellular delivery of active enzymes is challenging due to their low …

In-vivo tumor targeting of pluronic-based nano-carriers

JY Kim, WI Choi, YH Kim, G Tae, SY Lee, K Kim… - Journal of Controlled …, 2010 - Elsevier
Pluronic-based nano-carriers including bare forms that were composed of Pluronic F 68 (NC
(PF 68)) or Pluronic F 127 (NC (PF 127)), and chitosan-conjugated forms (Chito-NC (PF 68) …